Prescribing habits of vancomycin in the emergency department: Are we dosing appropriately?

Journal of Emergency Medicine

Volumn 44, Issue 5, 2013, Pages 979-984

  Rosini, Jamie M ^a   Grovola, Michael R ^a   Levine, Brian J ^a   Jasani, Neil B ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

dosing; Emergency Medicine; MRSA; vancomycin; weight based

Indexed keywords

VANCOMYCIN;

ADULT; AGE; AGED; ARTICLE; BACTEREMIA; BODY WEIGHT; CREATININE CLEARANCE; EMERGENCY WARD; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BODY WEIGHT; COHORT STUDIES; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; RETROSPECTIVE STUDIES; VANCOMYCIN; YOUNG ADULT;

EID: 84877576137     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2012.11.051     Document Type: Article

References (15)

1. C. Liu, A. Bayer, and S.E. Cosgrove Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children Clin Infect Dis 52 2011 e18 e55
2. M.L. Schweizer, J.P. Furuno, and A.D. Harris Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia BMC Infect Dis 11 2011 279
3. M. Rybak, B. Lomaestro, and J.C. Rotschafer Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Disease Pharmacists Am J Health Syst Pharm 66 2009 82 98
4. M. Rybak, B. Lomaestro, and J.C. Rotschafer Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Disease Pharmacists Clin Infect Dis 49 2009 325 327
5. R. Kullar, S.L. Davis, D.P. Levine, and M.J. Rybak Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets Clin Infect Dis 52 2011 975 981
6. M.J. Rybak The pharmacokinetic and pharmacodynamic properties of vancomycin Clin Infect Dis 42 Suppl 2006 S35 S39
7. W.A. Craig Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid Infect Dis Clin North Am 17 2003 479 501
8. R. Kullar, S.L. Davis, T.N. Taylor, K.S. Kaye, and M.J. Rybak Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort Pharmacotherapy 32 2012 195 201
9. A. Kumar, S. Roberts, and K.E. Wood Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 2006 1589 1596
10. T.P. Lodise, P.S. McKinnon, L. Swiderski, and M.J. Rybak Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia Clin Infect Dis 36 2003 1418 1423
11. L. Leibovici, L.L. Shraga, and I. Drucker The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infections J Intern Med 244 1998 379 386
12. E.H. Ibrahim, G. Sherman, and S. Ward The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 2000 146 155
13. G. Sakoulas, P.A. Moise-Broder, and J. Schentag Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2004 2398 2402
14. P.A. Moise, and J.J. Schentag Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections Int J Antimicrob Agents 16 Suppl 1 2000 S31 S34
15. P.A. Moise, G. Sakoulas, and G.M. Eliopoilos Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy Clin Infect Dis 38 2004 1700 1705